---
figid: PMC25360__mk0690891009
figlink: /pmc/articles/PMC25360/figure/F9/
number: F9
caption: Signaling pathways required for transformation by v-Src. v-Src activates
  both the Ras-MAPK pathway, which can be inhibited by coexpression of N17Ras or by
  PD98059, and, in parallel, the PI3K-Akt-mTOR pathway, which can be inhibited by
  LY294002 or rapamycin. Inhibition of both pathways is required to block transformation.
  Our data do not exclude the possibility that Src, Ras, and PI3K activate other pathways
  that are also necessary for transformation.
pmcid: PMC25360
papertitle: 'Transformation by v-Src: Ras-MAPK and PI3K-mTOR Mediate Parallel Pathways.'
reftext: Elicia Penuel, et al. Mol Biol Cell. 1999 Jun;10(6):1693-1703.
pmc_ranked_result_index: '59786'
pathway_score: 0.9536187
filename: mk0690891009.jpg
figtitle: Signaling pathways required for transformation by v-Src
year: '1999'
organisms:
- Homo sapiens
ndex: 5d1c69d7-dec8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC25360__mk0690891009.html
  '@type': Dataset
  description: Signaling pathways required for transformation by v-Src. v-Src activates
    both the Ras-MAPK pathway, which can be inhibited by coexpression of N17Ras or
    by PD98059, and, in parallel, the PI3K-Akt-mTOR pathway, which can be inhibited
    by LY294002 or rapamycin. Inhibition of both pathways is required to block transformation.
    Our data do not exclude the possibility that Src, Ras, and PI3K activate other
    pathways that are also necessary for transformation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - MAP2K1
  - MAP2K2
  - AKT2
  - AKT3
  - PIK3CD
  - PIK3R6
  - PIK3CG
  - MTOR
  - PIK3CB
  - BRAF
  - SRC
  - PIK3R5
  - AKT1
  - PIK3CA
  - PIK3R3
  - ARAF
  - RAF1
  - PIK3R4
  - LY294002
  - rapamycin
  - Cancer
genes:
- word: Erk2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: mTor
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: v-Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
chemicals:
- word: LY294002
  source: MESH
  identifier: C085911
- word: rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC25360__F9
redirect_from: /figures/PMC25360__F9
figtype: Figure
---
